Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 3.35 -0.19 (5.37%)
Previous Close $3.54    52 Week High
Open $3.36    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.26    EPS
Volume 23,098